Lazard Asset Management
RPRX icon

Lazard Asset Management’s Royalty Pharma RPRX Stock Holding History

Lazard Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Hold
24,163
– – ﹤0.01% 1127
2026
Q1 		$1.16M Sell
24,163
-108,947
-82% -$4.77M ﹤0.01% 1111
2025
Q4 		$5.14M Sell
133,110
-104,908
-44% -$4M 0.01% 546
2025
Q3 		$8.4M Buy
238,018
+42,370
+22% +$1.53M 0.01% 459
2025
Q2 		$7.05M Buy
195,648
+155,497
+387% +$5.15M 0.01% 636
2025
Q1 		$1.25M Buy
40,151
+16,694
+71% +$529K ﹤0.01% 1135
2024
Q4 		$598K Sell
23,457
-1,130
-5% -$30K ﹤0.01% 1310
2024
Q3 		$695K Sell
24,587
-5,137
-17% -$142K ﹤0.01% 1252
2024
Q2 		$783K Buy
+29,724
New +$824K ﹤0.01% 1042
2024
Q1 		– Sell
-29,702
Closed -$834K – 2335
2023
Q4 		$834K Sell
29,702
-28
-0.1% -$769 ﹤0.01% 989
2023
Q3 		$806K Hold
29,730
– – ﹤0.01% 1024
2023
Q2 		$913K Buy
29,730
+28
+0.1% +$948 ﹤0.01% 1004
2023
Q1 		$1.07M Sell
29,702
-2,709
-8% -$100K ﹤0.01% 1011
2022
Q4 		$1.28M Buy
32,411
+10
+0% +$417 ﹤0.01% 972
2022
Q3 		$1.3M Hold
32,401
– – ﹤0.01% 955
2022
Q2 		$1.36M Buy
+32,401
New +$1.33M ﹤0.01% 962
2021
Q1 		– Sell
-21,400
Closed -$1.07M – 1994
2020
Q4 		$1.07M Buy
+21,400
New +$908K ﹤0.01% 885

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management's RPRX Position: Q2 2026 in Review

Lazard Asset Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 24,163 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Lazard Asset Management first reported a position in RPRX in Q4 2020 and has held it in 17 quarters since. The position peaked at $8.4M in Q3 2025. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Lazard Asset Management held 24,163 shares of Royalty Pharma worth $1.35M as of Q2 2026.
  • Lazard Asset Management left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1127 holding.
  • Lazard Asset Management first reported a position in Royalty Pharma in Q4 2020 and has held it in 17 quarters since.
  • Lazard Asset Management's Royalty Pharma position peaked at $8.4M in Q3 2025.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.